Bruce C. Cozadd

2013

In 2013, Bruce C. Cozadd earned a total compensation of $8.3M as Chairman and Chief Executive Officer at Jazz Pharmaceuticals, a 26% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$1,056,500
Option Awards$3,478,750
Salary$771,154
Stock Awards$2,956,500
Other$3,622
Total$8,266,526

Cozadd received $3.5M in option awards, accounting for 42% of the total pay in 2013.

Cozadd also received $1.1M in non-equity incentive plan, $771.2K in salary, $3M in stock awards and $3.6K in other compensation.

Rankings

In 2013, Bruce C. Cozadd's compensation ranked 586th out of 12,286 executives tracked by ExecPay. In other words, Cozadd earned more than 95.2% of executives.

ClassificationRankingPercentile
All
586
out of 12,286
95th
Division
Manufacturing
181
out of 4,612
96th
Major group
Chemicals And Allied Products
44
out of 1,466
97th
Industry group
Drugs
26
out of 1,160
98th
Industry
Pharmaceutical Preparations
24
out of 890
97th
Source: SEC filing on June 20, 2016.

Cozadd's colleagues

We found four more compensation records of executives who worked with Bruce C. Cozadd at Jazz Pharmaceuticals in 2013.

2013

Suzanne Hooper

Jazz Pharmaceuticals

General Counsel

2013

Kathryn Falberg

Jazz Pharmaceuticals

Chief Financial Officer

2013

Russell Cox

Jazz Pharmaceuticals

Chief Operating Officer

2013

Fintan Keegan

Jazz Pharmaceuticals

Executive Vice President, Technical Operations

News

You may also like